About Christopher Cashman
Form D filings for MBF Therapeutics from 2009 to 2024 list Christopher Cashman as director.
Christopher Cashman first appears on SEC filings in 2009.
Experience
This experience comes from SEC filings. The years are when the filings name Christopher Cashman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Christopher Cashman works with at each company, as listed on that company's latest Form D.
MBF Therapeutics, Inc. · Form D, Jan 8, 2024
DT
Dhiren Thakker
Director
JC
Joseph Connor
Director
AP
Aris Persidis
Director
LK
Lorraine Keller
Executive officer
TT
Thomas Tillett
President and director